By Counterforce Health Team in Ultomiris (ravulizumab) —

Work With Your Doctor to Get Ultomiris (Ravulizumab) Approved by Blue Cross Blue Shield in Washington: Provider Partnership Guide

Answer Box: Getting Ultomiris Covered in Washington

To get Ultomiris (ravulizumab) approved by Blue Cross Blue Shield in Washington, you need prior authorization with specific clinical documentation for PNH, aHUS, myasthenia gravis, or NMOSD. Your doctor must submit lab results (flow cytometry for PNH, complement studies for aHUS), proof of meningococcal vaccination, REMS enrollment, and evidence of medical necessity. If denied, Washington's external review process through an Independent Review Organization provides a binding appeal within 4 months. Start by calling your Blue Cross plan's member services to confirm your specific formulary status and prior authorization requirements.

Table of Contents

  1. Set Your Goal: Understanding Approval Requirements
  2. Visit Preparation: What to Document
  3. Building Your Evidence Kit
  4. Medical Necessity Letter Structure
  5. Supporting Peer-to-Peer Reviews
  6. After-Visit Documentation
  7. Respectful Persistence Strategy
  8. Washington Appeals Process
  9. Common Denial Reasons & Solutions
  10. FAQ

Set Your Goal: Understanding Approval Requirements

Ultomiris (ravulizumab) requires prior authorization from all Blue Cross Blue Shield plans for its FDA-approved indications: paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), generalized myasthenia gravis (gMG), and neuromyelitis optica spectrum disorder (NMOSD). The annual cost often exceeds $470,000, making thorough documentation critical.

Your partnership with your provider centers on three goals:

  • Demonstrating medical necessity through lab results and clinical history
  • Meeting REMS safety requirements including meningococcal vaccination
  • Addressing potential step therapy requirements (some plans require Empaveli first)
Note: Blue Cross Blue Shield operates as 33 independent plans. Washington residents primarily have Premera Blue Cross or Regence BlueShield, each with potentially different formulary requirements.

Visit Preparation: What to Document

Before your appointment, create a comprehensive symptom and treatment timeline. This preparation enables your doctor to write a compelling medical necessity letter.

Symptom Timeline Documentation

Track these details for the past 6-12 months:

  • Frequency and severity of breakthrough symptoms (fatigue, shortness of breath, blood clots for PNH)
  • Functional impact on daily activities, work, or school
  • Emergency department visits or hospitalizations related to your condition
  • Transfusion requirements and dates (especially important for PNH)

Prior Treatment History

Document all previous therapies with specific details:

  • Medication names, doses, and duration of treatment
  • Reasons for discontinuation (lack of efficacy, side effects, contraindications)
  • Laboratory evidence of treatment failure (rising LDH, declining hemoglobin)
  • Allergic reactions or intolerances to alternative treatments

Building Your Evidence Kit

Work with your healthcare team to compile comprehensive clinical evidence. Different conditions require specific laboratory documentation.

Laboratory Requirements by Condition

Condition Required Tests Documentation Purpose
PNH Flow cytometry (≥2 reagents, ≥2 cell lines), baseline LDH (≥1.5x ULN), hemoglobin levels Confirm diagnosis and disease activity
aHUS Negative Shiga toxin test, complement studies, baseline LDH/creatinine, platelet count Rule out STEC-HUS, confirm TMA
gMG Anti-AChR antibody testing, baseline LDH Confirm antibody-positive disease
NMOSD Anti-AQP4 antibody testing, MRI evidence Establish diagnosis and disease activity

REMS and Safety Documentation

All patients need:

  • Meningococcal vaccination records (serogroups A, B, C, W, Y) administered ≥2 weeks before treatment
  • REMS program enrollment confirmation from prescriber
  • Baseline infection screening to rule out active meningococcal disease

Medical Necessity Letter Structure

Your doctor's letter to Blue Cross Blue Shield should follow this proven structure for maximum impact.

Essential Components

1. Clinical Problem Statement

  • Clear diagnosis with ICD-10 codes
  • Disease severity and progression
  • Impact on quality of life and function

2. Prior Treatment Documentation

  • Chronological list of previous therapies
  • Specific reasons for failure or discontinuation
  • Laboratory evidence supporting treatment changes

3. Clinical Rationale for Ultomiris

  • FDA-approved indication match
  • Expected therapeutic benefit
  • Monitoring plan and safety measures

4. Supporting Evidence

Clinician Corner: Include specific laboratory values with normal ranges, dates of testing, and trends over time. Payers respond better to objective data than subjective symptom descriptions alone.

Supporting Peer-to-Peer Reviews

If your initial prior authorization is denied, many Blue Cross plans offer peer-to-peer review opportunities where your doctor speaks directly with the plan's medical director.

Preparing Your Provider

  • Offer flexible scheduling by providing multiple availability windows
  • Prepare a concise case summary highlighting the most compelling evidence
  • Anticipate common questions about alternative treatments and safety monitoring
  • Have lab results readily available during the call

Key Talking Points for Your Doctor

  • Specific contraindications to step therapy alternatives
  • Disease progression despite conventional treatments
  • Risk of serious complications without prompt treatment
  • Compliance with REMS safety requirements

After-Visit Documentation

Maintain organized records of all interactions and submissions to support potential appeals.

Essential Documents to Save

  • Copies of all prior authorization submissions with timestamps
  • Provider portal screenshots showing submission status
  • All correspondence from Blue Cross Blue Shield including denial letters
  • Clinical notes from appointments discussing treatment decisions

Patient Portal Communication

Use your provider's patient portal strategically:

  • Message timing: Allow 2-3 business days for responses to non-urgent questions
  • Concise requests: Limit messages to one specific question or request
  • Documentation requests: Ask for copies of submitted PA forms and supporting documents

Respectful Persistence Strategy

Maintaining professional relationships while advocating for coverage requires balanced communication.

Appropriate Follow-Up Cadence

  • Initial submission: Wait 15 business days before first follow-up
  • Pending decisions: Check status weekly via provider portal
  • Denied requests: Schedule appeal discussion within 5 business days

Escalation Guidelines

If your provider seems unresponsive or unwilling to pursue appeals:

  • Request a second opinion from another specialist in your network
  • Contact patient advocacy services at your healthcare system
  • Seek assistance from Counterforce Health, which specializes in turning insurance denials into targeted, evidence-backed appeals

Washington Appeals Process

Washington state provides robust consumer protections for insurance denials, including binding external review.

Internal Appeals Timeline

  • First-level internal appeal: 180 days from denial notice
  • Standard review: 15-30 days for decision
  • Expedited review: 72 hours for urgent cases

External Review Process

If internal appeals fail, Washington's external review process provides independent evaluation:

  • Filing deadline: 4 months after final internal denial
  • Standard timeline: 45 days for IRO decision
  • Expedited timeline: 72 hours for urgent cases
  • Cost: Free through federal process, maximum $25 for private IRO

Submit external reviews to:

Common Denial Reasons & Solutions

Denial Reason Solution Strategy Required Documentation
Step therapy not completed Document contraindications or failures of required first-line treatments Prior therapy records, allergy documentation, lab evidence of failure
Not medically necessary Strengthen clinical rationale with objective measures Disease severity markers, functional assessments, specialist recommendations
Experimental/investigational Emphasize FDA approval for your specific indication FDA prescribing information, clinical guidelines, peer-reviewed studies
Quantity/frequency limits Justify dosing based on clinical response and monitoring Therapeutic drug levels, disease activity markers, specialist dosing rationale

FAQ

How long does Blue Cross Blue Shield prior authorization take in Washington? Standard prior authorization decisions typically take 15 business days. Expedited reviews for urgent cases must be completed within 72 hours.

What if Ultomiris is non-formulary on my plan? Request a formulary exception by demonstrating medical necessity and providing evidence that formulary alternatives are inappropriate or have failed.

Can I request an expedited appeal if my condition is worsening? Yes, if waiting for a standard appeal timeline would jeopardize your health or ability to regain maximum function, you can request expedited review at both internal and external appeal levels.

Does step therapy apply if I failed similar treatments outside Washington? Step therapy requirements typically accept documented failures from any provider, but you must provide complete medical records showing the trial and reason for discontinuation.

Who can help if my doctor won't submit a prior authorization? Contact your healthcare system's patient advocacy services, seek a second opinion from another in-network specialist, or consider services like Counterforce Health that help patients navigate complex coverage challenges.

What's the difference between internal and external appeals in Washington? Internal appeals are reviewed by your insurance company's medical staff, while external appeals are conducted by independent medical experts through an IRO. External review decisions are binding on your insurer.

This article provides educational information about insurance coverage and is not medical advice. For personalized guidance about your specific situation, consult with your healthcare provider and insurance plan. Washington residents can contact the Office of the Insurance Commissioner at 1-800-562-6900 for assistance with appeals and coverage disputes.

Sources & Further Reading

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.